MARKET

TTPH

TTPH

Tetraphase
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3263
-0.0118
-3.49%
Closed 17:20 09/17 EDT
OPEN
0.3500
PREV CLOSE
0.3381
HIGH
0.3529
LOW
0.3180
VOLUME
393.07K
TURNOVER
--
52 WEEK HIGH
3.205
52 WEEK LOW
0.2250
MARKET CAP
17.72M
P/E (TTM)
-0.2099
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TTPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TTPH News

  • What Kind Of Shareholder Owns Most Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Stock?
  • Simply Wall St..5d ago
  • Benzinga's Top Upgrades, Downgrades For September 3, 2019
  • Benzinga.09/03 13:42
  • H.C. Wainwright Downgrades Tetraphase Pharmaceutical to Neutral
  • Benzinga.09/03 12:10
  • Edited Transcript of TTPH earnings conference call or presentation 8-Aug-19 8:30pm GMT
  • Thomson Reuters StreetEvents.09/02 21:33

More

Industry

Pharmaceuticals
+0.65%
Pharmaceuticals & Medical Research
+0.57%

Hot Stocks

Name
Price
%Change

About TTPH

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections. The Company also develops TP-6076 for multidrug-resistant gram-negative infections. Eravacycline is a fluorocycline antibiotic. The Company is conducting a global Phase III clinical program for eravacycline called Investigating Gram-Negative Infections Treated with Eravacycline (IGNITE). TP-271 is a fully synthetic fluorocycline being developed for respiratory disease caused by bacterial biothreat pathogens in healthy volunteers.
More

Webull offers Tetraphase Pharmaceuticals Inc (TTPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.